Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4 ACTs for Uncomplicated Malaria in African Children
NCT00393679Phase 3Completed
- Sponsor
- Institute of Tropical Medicine Antwerp
- Start
- Jul 2007
- Primary completion
- Dec 2009
- Modality
- Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 7
01
Overview
A Phase 3 trial of artesunate + amodiaquine, dihydroartemisinin + piperaquine, artemether + lumefantrine, chlorproguanil + dapsone + artesunate in malaria, sponsored by Institute of Tropical Medicine Antwerp. Started Jul 2007; status: completed.
02
Drugs
artesunate + amodiaquinedihydroartemisinin + piperaquineartemether + lumefantrinechlorproguanil + dapsone + artesunate
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00393679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00393679.